Biotech · Private company · La Jolla, CA, US

Turnstone Biologics Corp.

SEC CIK 0001764974

Track this companyFree. Adds Turnstone Biologics Corp. to your Dealase workspace and tells you when its record changes.

Clinical trials50 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline7

TBio-4101 and Pembro wi/ or w/o Chemo in Recurrent/Metastatic HNSCCPHASE1 · COMPLETED · started Mar 14, 2024ClinicalTrials.gov NCT06236425 · fetched Nov 12, 2026
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid TumorsPHASE1 · TERMINATED · started Jan 17, 2023ClinicalTrials.gov NCT05576077 · fetched Nov 12, 2026
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory MelanomaPHASE1 · COMPLETED · started Nov 22, 2022ClinicalTrials.gov NCT05628883 · fetched Nov 12, 2026
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsPHASE1 · TERMINATED · started Jun 2, 2020ClinicalTrials.gov NCT04301011 · fetched Nov 12, 2026
This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated CancersPHASE1 · TERMINATED · started Jun 21, 2018ClinicalTrials.gov NCT03618953 · fetched Nov 12, 2026